IPFL deploys BMF micro 3D printing for MedTech batch production of microfluidics and microneedles

IPFL, a precision plastics specialist, is moving micro 3D printing from R&D into batch production for medical devices, deploying Boston Micro Fabrication (BMF) technology on the manufacturing floor. Manufacturing Engineer Adam Bloomfield detailed the deployment in a video interview, highlighting clinical demand for miniaturization in microfluidics, microneedle arrays, and endoscope shells. IPFL is leveraging BMF's multi-resolution printing capabilities, switching between 10µm and 25µm layer resolutions to optimize build speed and cost per part. The company is also addressing resin clearance and optical clarity using low-viscosity, clear biocompatible materials.

This deployment represents a practical step in the medical-dental vertical's long qualification grind, where micro AM has often stalled at the prototyping stage due to material certification and throughput constraints. IPFL's move to batch production with BMF's platform suggests that micro-stereolithography is finding a viable economic niche where injection molding tooling costs are prohibitive for low-to-mid volume runs. The focus on microfluidics and microneedles aligns with the broader trend of device miniaturization driven by minimally invasive procedures and point-of-care diagnostics.

The practical takeaway for MedTech manufacturers is that micro 3D printing is no longer solely a rapid prototyping tool but a legitimate bridge to production for complex micro-scale geometries. IPFL's hybrid print approach, combining high-resolution features with faster coarser layers, directly addresses the cost-per-part economics that have historically limited micro AM adoption. This case reinforces that service bureaus, not just OEMs, are the primary channel for scaling AM into regulated medical production.